The Medicine Box / The Medicine Box: Kearney’s Saumya Krishna explains how ‘Make In India’ can fuel 4x growth in vaccines, biosimilars by 2026

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.